{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:16Z","timestamp":1792189156759,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China from Ministry of Science and Technology of the People\u2019s Republic of China","award":["2021YFC2500804"],"award-info":[{"award-number":["2021YFC2500804"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09873-1","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:02:02Z","timestamp":1726808522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identifying optimal serum 1,3-\u03b2-D-Glucan cut-off for diagnosing Pneumocystis Jirovecii Pneumonia in non-HIV patients in the intensive care unit"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuan-Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Min","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"9873_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","volume":"96","author":"A Kanj","year":"2021","unstructured":"Kanj A, Samhouri B, Abdallah N, Chehab O, Baqir M. Host factors and outcomes in hospitalizations for Pneumocystis Jirovecii Pneumonia in the United States. Mayo Clin Proc. 2021;96:400\u20137.","journal-title":"Mayo Clin Proc"},{"key":"9873_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22:307.","journal-title":"Crit Care"},{"key":"9873_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","volume":"46","author":"AL Bienvenu","year":"2016","unstructured":"Bienvenu AL, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S. Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis. 2016;46:11\u20137.","journal-title":"Int J Infect Dis"},{"key":"9873_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/crj.13463","volume":"16","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang X, Sun T, Fan G, Zhan Q, Weng L. Non-HIV\u2010infected patients with Pneumocystis pneumonia in the intensive care unit: a bicentric, retrospective study focused on predictive factors of in\u2010hospital mortality. Clin Respir J. 2022;16:152\u201361.","journal-title":"Clin Respir J"},{"key":"9873_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12879-016-1855-x","volume":"16","author":"L Weng","year":"2016","unstructured":"Weng L, Huang X, Chen L, Feng L-Q, Jiang W, Hu X-Y, et al. Prognostic factors for severe pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study. BMC Infect Dis. 2016;16:528.","journal-title":"BMC Infect Dis"},{"key":"9873_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1128\/JCM.02091-07","volume":"46","author":"F Persat","year":"2008","unstructured":"Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1\u21923)- \u03b2- D -Glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2008;46:1009\u201313.","journal-title":"J Clin Microbiol"},{"key":"9873_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/JCM.05267-11","volume":"50","author":"A Onishi","year":"2012","unstructured":"Onishi A, Sugiyama D, Kogata Y, Saeusa J, Sugimoto T, Kawano S, et al. Diagnostic accuracy of serum 1,3-\u03b2-d-Glucan for Pneumocystis Jiroveci Pneumonia, Invasive Candidiasis, and invasive aspergillosis: systematic review and Meta-analysis. J Clin Microbiol. 2012;50:7\u201315.","journal-title":"J Clin Microbiol"},{"key":"9873_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the Consensus definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71:1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"9873_CR9","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ, Ruhnke M, Shoham S, Vazquez J, et al. EORTC\/MSGERC definitions of Invasive Fungal diseases: Summary of activities of the Intensive Care Unit Working Group. Clin Infect Dis. 2021;72:S121\u20137.","journal-title":"Clin Infect Dis"},{"key":"9873_CR10","doi-asserted-by":"publisher","first-page":"713265","DOI":"10.3389\/fmicb.2021.713265","volume":"12","author":"C Damiani","year":"2021","unstructured":"Damiani C, Demey B, Pauc C, Le Govic Y, Totet A. A negative (1,3)-\u03b2-D-glucan result alone is not sufficient to rule out a diagnosis of pneumocystis pneumonia in patients with hematological malignancies. Front Microbiol. 2021;12:713265.","journal-title":"Front Microbiol"},{"key":"9873_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmi.2020.05.024","volume":"26","author":"O Del Corpo","year":"2020","unstructured":"Del Corpo O, Butler-Laporte G, Sheppard DC, Cheng MP, McDonald EG, Lee TC. Diagnostic accuracy of serum (1\u20133)-\u03b2-D-glucan for Pneumocystis Jirovecii pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26:1137\u201343.","journal-title":"Clin Microbiol Infect"},{"key":"9873_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13054-023-04608-1","volume":"27","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, et al. Pneumocystis Jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care. 2023;27:323.","journal-title":"Crit Care"},{"key":"9873_CR13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/JCM.03174-15","volume":"54","author":"T Fauchier","year":"2016","unstructured":"Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C. Detection of Pneumocystis jirovecii by quantitative PCR to Diifferentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patinets. J Clin Microbiol. 2016;54:1487\u201395.","journal-title":"J Clin Microbiol"},{"key":"9873_CR14","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","volume":"50","author":"Y Lu","year":"2011","unstructured":"Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, Wang K. Diagnosis of invasive fungal disease using serum (1\u20133) -\u03b2-D -glucan: a bivariate meta-analysis. Intern Med. 2011;50:2783\u201391.","journal-title":"Intern Med"},{"key":"9873_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11046-017-0132-x","volume":"182","author":"T Lahmer","year":"2017","unstructured":"Lahmer T, da Costa CP, Held J, Rasch S, Ehmer U, Schmid RM, et al. Usefulness of 1,3 Beta-d-Glucan detection in non-HIV immunocompromised mechanical ventilated critically ill patients with ARDS and suspected pneumocystis jirovecii pneumonia. Mycopathologia. 2017;182:701\u20138.","journal-title":"Mycopathologia"},{"key":"9873_CR16","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.18632\/oncotarget.7471","volume":"7","author":"E Azoulay","year":"2016","unstructured":"Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatuchet A, et al. (1, 3)-\u03b2-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget. 2016;7:21484\u201395.","journal-title":"Oncotarget"},{"key":"9873_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, et al. \u03b2- d -Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39:199\u2013205.","journal-title":"Clin Infect Dis"},{"key":"9873_CR18","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1177\/09564624211022247","volume":"32","author":"T Juniper","year":"2021","unstructured":"Juniper T, Eades CP, Gil E, Fodder H, Quinn K, Morris-Jones S, et al. Use of \u03b2-D-glucan in diagnosis of suspected Pneumocystis Jirovecii pneumonia in adults with HIV infection. Int J STD AIDS. 2021;32:1074\u20137.","journal-title":"Int J STD AIDS"},{"key":"9873_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jinf.2020.07.003","volume":"81","author":"AD Szvalb","year":"2020","unstructured":"Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DP. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis Jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect. 2020;81:443\u201351.","journal-title":"J Infect"},{"key":"9873_CR20","doi-asserted-by":"crossref","unstructured":"Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-Beta- D -glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59. e0327620.","DOI":"10.1128\/JCM.03276-20"},{"key":"9873_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/cid\/ciy1072","volume":"69","author":"S Morjaria","year":"2019","unstructured":"Morjaria S, Frame J, Franco-Garcia A, Geyer A, Kamboj M, Babady NE. Clinical performance of (1,3) Beta-D glucan for the diagnosis of pneumocystis pneumonia in cancer patients tested with PCP polymerase chain reaction. Clin Infect Dis. 2019;69:1303\u20139.","journal-title":"Clin Infect Dis"},{"key":"9873_CR22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.rmed.2014.09.017","volume":"108","author":"D Salerno","year":"2014","unstructured":"Salerno D, Mushatt D, Myers L, Zhuang Y, De la Rua N, Calderon EJ, et al. Serum and bal beta-d-glucan for the diagnosis of pneumocystis pneumonia in HIV positive patients. Respir Med. 2014;108:1688\u201395.","journal-title":"Respir Med"},{"key":"9873_CR23","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1128\/JCM.01756-09","volume":"47","author":"S Desmet","year":"2009","unstructured":"Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De Munter P, et al. Serum (1\u20133)-\u03b2- D -Glucan as a tool for diagnosis of pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol. 2009;47:3871\u20134.","journal-title":"J Clin Microbiol"},{"key":"9873_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/myc.12997","volume":"62","author":"G Desoubeaux","year":"2019","unstructured":"Desoubeaux G, Chesnay A, Mercier V, Cachinho Bras J, Moshiri P, Eymieux S, et al. Combination of \u03b2- (1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis Jirovecii pneumonia. Mycoses. 2019;62:1015\u201322.","journal-title":"Mycoses"},{"key":"9873_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10096-014-2302-9","volume":"34","author":"H Hammarstr\u00f6m","year":"2015","unstructured":"Hammarstr\u00f6m H, Kondori N, Friman V, Wenner\u00e5s C. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors. Eur J Clin Microbiol Infect Dis. 2015;34:917\u201325.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9873_CR26","first-page":"882","volume":"10","author":"J Digby","year":"2003","unstructured":"Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol. 2003;10:882\u20135.","journal-title":"Clin Diagn Lab Immunol"},{"key":"9873_CR27","doi-asserted-by":"crossref","unstructured":"Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V et al. Reactivity of (1,3)-beta-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 201;30:1450\u201360.","DOI":"10.1007\/s10096-011-1244-8"},{"key":"9873_CR28","doi-asserted-by":"crossref","unstructured":"Monique ASH, Mennink-Kersten D, Ruegebrink PE, Verweij. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. CID. 2008:46:1930\u20131.","DOI":"10.1086\/588563"},{"key":"9873_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.idc.2006.06.009","volume":"20","author":"MA Mennink-Kersten","year":"2006","unstructured":"Mennink-Kersten MA, Verweij PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin North Am. 2006;20:711\u201327.","journal-title":"Infect Dis Clin North Am"},{"key":"9873_CR30","doi-asserted-by":"crossref","unstructured":"G\u00f6khan M 1. Ayse Nedret Koc, \u00c7i\u011fdem A\u011fku\u015f, Leyla G\u00fcl Kaynar, Emine Alp, B\u00fclent Eser. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Rev Iberoam Micol. 2012;29:169\u201371.","DOI":"10.1016\/j.riam.2011.07.003"},{"key":"9873_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/jof7121046","volume":"7","author":"M Mikulska","year":"2021","unstructured":"Mikulska M, Balletto E, Castagnola E, Mularoni A. Beta-D-Glucan in patients with haematological malignancies. J Fungi (Basel). 2021;7:1046.","journal-title":"J Fungi (Basel)"},{"key":"9873_CR32","doi-asserted-by":"publisher","first-page":"e0169122","DOI":"10.1128\/jcm.01691-22","volume":"61","author":"A Kritikos","year":"2023","unstructured":"Kritikos A, Caruana G, Poissy J, Mamin A, Bachmann D, Pagani JL, et al. Comparison of three \u03b2-Glucan tests for the diagnosis of invasive candidiasis in intensive care units. J Clin Microbiol. 2023;61:e0169122.","journal-title":"J Clin Microbiol"},{"key":"9873_CR33","doi-asserted-by":"publisher","first-page":"e00322","DOI":"10.1128\/JCM.00322-19","volume":"57","author":"T Mercier","year":"2019","unstructured":"Mercier T, Guldentops E, Patteet S, Beuselinck K, Lagrou K, Maertens J. Beta- D -Glucan for diagnosing pneumocystis pneumonia: a direct comparison between the Wako \u03b2-Glucan assay and the Fungitell Assay. J Clin Microbiol. 2019;57:e00322\u201319.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09873-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:02:46Z","timestamp":1726808566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09873-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9873"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09873-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4604554\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Peking Union Medical College Hospital approved the study under number K23C3112. Given that the study was noninterventional and retrospective in nature with anonymized data, written informed consent had been waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1015"}}